---
---

# 21 U.S.C., USLM ref /us/usc/t21/s1602

* Portions Copyright © 2016 the authors of the https://github.com/publicdocs project.
  Use of this file is subject to the NOTICE at [https://github.com/publicdocs/uscode/blob/master/NOTICE](https://github.com/publicdocs/uscode/blob/master/NOTICE)
* See the [Document Metadata](././../../../..//README.md) for more information.
  This file is generated from historical government data; content and/or formatting may be inaccurate and out-of-date and should not be used for official purposes.

----------
----------

[Previous](./../../../..//us/usc/t21/ch21/m__us_usc_t21_s1601.md) | [Next](./../../../..//us/usc/t21/ch21/m__us_usc_t21_s1603.md) | [Root of Title](./../../../../) | [Other Versions of this Document](https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft21%2Fs1602)

## § 1602. Definitions

     As used in this chapter:

    (1) __Biomaterials supplier__ 

        (A) __In general__ 

            The term “biomaterials supplier” means an entity that directly or indirectly supplies a component part or raw material for use in the manufacture of an implant.

        (B) __Persons included__ 

        Such term includes any person who—

            (i) has submitted master files to the Secretary for purposes of premarket approval of a medical device; or

            (ii) licenses a biomaterials supplier to produce component parts or raw materials.

    (2) __Claimant__ 

        (A) __In general__ 

            The term “claimant” means any person who brings a civil action, or on whose behalf a civil action is brought, arising from harm allegedly caused directly or indirectly by an implant, including a person other than the individual into whose body, or in contact with whose blood or tissue, the implant is placed, who claims to have suffered harm as a result of the implant.

        (B) __Action brought on behalf of an estate__ 

            With respect to an action brought on behalf of or through the estate of a deceased individual into whose body, or in contact with whose blood or tissue the implant was placed, such term includes the decedent that is the subject of the action.

        (C) __Action brought on behalf of a minor or incompetent__ 

            With respect to an action brought on behalf of or through a minor or incompetent, such term includes the parent or guardian of the minor or incompetent.

        (D) __Exclusions__ 

        Such term does not include—

            (i)

             a provider of professional health care services in any case in which—

                (I) the sale or use of an implant is incidental to such services; and

                (II) the essence of the professional health care services provided is the furnishing of judgment, skill, or services;

            (ii) a person acting in the capacity of a manufacturer, seller, or biomaterials supplier; or

            (iii)

             a person alleging harm caused by either the silicone gel or the silicone envelope utilized in a breast implant containing silicone gel, except that—

                (I) neither the exclusion provided by this clause nor any other provision of this chapter may be construed as a finding that silicone gel (or any other form of silicone) may or may not cause harm; and

                (II)

                 the existence of the exclusion under this clause may not—

                    (aa) be disclosed to a jury in any civil action or other proceeding; and

                    (bb) except as necessary to establish the applicability of this chapter, otherwise be presented in any civil action or other proceeding.

    (3) __Component part__ 

        (A) __In general__ 

            The term “component part” means a manufactured piece of an implant.

        (B) __Certain components__ 

        Such term includes a manufactured piece of an implant that—

            (i) has significant non-implant applications; and

            (ii) alone, has no implant value or purpose, but when combined with other component parts and materials, constitutes an implant.

    (4) __Harm__ 

        (A) __In general__ 

        The term “harm” means—

            (i) any injury to or damage suffered by an individual;

            (ii) any illness, disease, or death of that individual resulting from that injury or damage; and

            (iii) any loss to that individual or any other individual resulting from that injury or damage.

        (B) __Exclusion__ 

            The term does not include any commercial loss or loss of or damage to an implant.

    (5) __Implant__ 

    The term “implant” means—

        (A)

         a medical device that is intended by the manufacturer of the device—

            (i) to be placed into a surgically or naturally formed or existing cavity of the body for a period of at least 30 days; or

            (ii) to remain in contact with bodily fluids or internal human tissue through a surgically produced opening for a period of less than 30 days; and

        (B) suture materials used in implant procedures.

    (6) __Manufacturer__ 

    The term “manufacturer” means any person who, with respect to an implant—

        (A) is engaged in the manufacture, preparation, propagation, compounding, or processing (as defined in [section 360(a)(1) of this title][/us/usc/t21/s360/a/1]) of the implant; and

        (B)

         is required—

            (i) to register with the Secretary pursuant to [section 360 of this title][/us/usc/t21/s360] and the regulations issued under such section; and

            (ii) to include the implant on a list of devices filed with the Secretary pursuant to [section 360(j) of this title][/us/usc/t21/s360/j] and the regulations issued under such section.

    (7) __Medical device__ 

        The term “medical device” means a device, as defined in [section 321(h) of this title][/us/usc/t21/s321/h], and includes any device component of any combination product as that term is used in [section 353(g) of this title][/us/usc/t21/s353/g].

    (8) __Raw material__ 

    The term “raw material” means a substance or product that—

        (A) has a generic use; and

        (B) may be used in an application other than an implant.

    (9) __Secretary__ 

        The term “Secretary” means the Secretary of Health and Human Services.

    (10) __Seller__ 

        (A) __In general__ 

            The term “seller” means a person who, in the course of a business conducted for that purpose, sells, distributes, leases, packages, labels, or otherwise places an implant in the stream of commerce.

        (B) __Exclusions__ 

        The term does not include—

            (i) a seller or lessor of real property;

            (ii)

             a provider of professional health care services in any case in which—

                (I) the sale or use of the implant is incidental to such services; and

                (II) the essence of the professional health care services provided is the furnishing of judgment, skill, or services; or

            (iii) any person who acts in only a financial capacity with respect to the sale of an implant.

([Pub. L. 105–230][/us/pl/105/230], § 3, Aug. 13, 1998, [112 Stat. 1520][/us/stat/112/1520].)

----------

[Previous](./../../../..//us/usc/t21/ch21/m__us_usc_t21_s1601.md) | [Next](./../../../..//us/usc/t21/ch21/m__us_usc_t21_s1603.md) | [Root of Title](./../../../../) | [Other Versions of this Document](https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft21%2Fs1602)

----------
----------

[/us/usc/t21/s360/a/1]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft21%2Fs360%2Fa%2F1
[/us/usc/t21/s360]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft21%2Fs360
[/us/usc/t21/s360/j]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft21%2Fs360%2Fj
[/us/usc/t21/s321/h]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft21%2Fs321%2Fh
[/us/usc/t21/s353/g]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft21%2Fs353%2Fg
[/us/pl/105/230]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F105%2F230
[/us/stat/112/1520]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fstat%2F112%2F1520


